The collaboration will open the next chapter in individual wellness and clinical governance by integrating genetic data, biomarkers, nutrition, and artificial intelligence.
DUBAI, UAE, OCTOBER , 2026: American Hospital Dubai and 10XREVIV, a Masdar City, Abu Dhabi-based precision-wellness and health-technology company, signed a non-binding Memorandum of Understanding (MoU) to collaborate on promoting precision, preventive and longevity healthcare in the UAE and the region.
10XREVIV operates across precision nutrition, women’s health, longevity, advanced therapeutics and human optimization medicine fields, and has developed the MYiOX Health consumer platform and the MYiOX Pro clinician software, along with nutritional engineering and genetic analysis services.
The MoU covers deploying 10XREVIV’s MYiOX Health consumer platform and MYiOX Pro clinician software with American Hospital Dubai’s systems for precision nutrition, longevity and healthy ageing; supportive oncology programmes; clinician education and research; and support for American Hospital Dubai’s Centre of Excellence in longevity and healthy ageing.
The MYiOX Health and MYiOX Pro are designed to close the gap between individual wellness and clinical governance by integrating genetic data, biomarkers, nutrition, and artificial intelligence into a continuum of care to produce tangible outcomes.
Sherif Beshara, Group CEO of American Hospital Dubai, said, “Our signing of the MoU with 10XREVIV is another milestone in our commitment to advancing transformative healthcare in the UAE and the region.
“As leading healthcare providers in the region, we are passionate about empowering people to live healthier lives and helping them turn the availability of personal health data into tangible health outcomes. The time for this advancement has come, and American Hospital Dubai is at the vanguard. Interoperability between our state-of-the-art medical infrastructure and clinical excellence and 10XREVIV’s next-generation systems will open new horizons in personalized medicine.
“We look forward to this exciting collaboration.”
Brandon Dawson, Chairman & Co-Founder, 10XREVIV, said, “American Hospital Dubai is recognized across the region for clinical excellence and innovation, and we’re pleased to be working together. Our shared goal is to use data-driven, personalized health tools to support prevention, recovery and healthy ageing for patients in the UAE and the wider region. This collaboration is an important milestone in 10XREVIV’s global expansion and in our mission to advance the intersection of precision health, technology and human longevity, with the shared goal of helping people live healthier, longer lives.”
Following the MoU, American Hospital Dubai and 10XREVIV will implement the programmes under American Hospital Dubai’s clinical governance system and in accordance with UAE regulatory approvals.
ABOUT AMERICAN HOSPITAL DUBAI:
American Hospital Dubai, established in 1996, is the flagship brand of the Mohammad & Obaid AlMulla Group and a regional healthcare leader, offering world-class medical services supported by cutting-edge technology and innovations. As a Mayo Clinic Network Member (MCNM) with many firsts in international accreditations, American Hospital Dubai invests in AI, Research, and Education to bring new healthcare solutions to people. The hospital has consistently set standards for quality treatment, processes, and patient-focused care, and its research breakthroughs help improve medical efficiency and care outcomes.
ABOUT 10XREVIV:
10XREVIV is a precision-wellness and health-technology company working across precision nutrition, women’s health, longevity, advanced therapeutics and human optimisation. It develops the MYiOX Health consumer platform and the MYiOX Pro clinician software, alongside nutritional engineering and genetic analysis services. 10XREVIV operates in the United Arab Emirates through 10X Reviv Trading Limited, licensed in Masdar City Free Zone, Abu Dhabi.
